10 results
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
, injunctions, civil penalties, restrictions on the product or on the manufacturing or laboratory facility, including license revocation, marketed product recall … but not limited to:
regulatory authorities may withdraw approvals of such product and cause AMTI to recall AMTI’s products;
regulatory authorities
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
, restrictions on the product or on the manufacturing or laboratory facility, including license revocation, marketed product recall, suspension … to:
regulatory authorities may withdraw approvals of such product and cause AMTI to recall AMTI’s products;
regulatory authorities may require additional
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
, restrictions on the product or on the manufacturing or laboratory facility, including license revocation, marketed product recall, suspension of manufacturing … to:
regulatory authorities may withdraw approvals of such product and cause AMTI to recall AMTI’s products;
regulatory authorities may require additional warnings
425
EX-2.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Sep 23
Business combination disclosure
4:28pm
Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
8-K
EX-2.1
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Sep 23
Cyclo Therapeutics, Inc. and Applied Molecular Transport Inc. Enter into a Definitive Merger Agreement
4:28pm
Product, (ii) withdraws its approval of, requests the recall, suspension, or seizure of, or withdraws or orders the withdrawal of advertising or sales
8-K
EX-1.1
9x6zgnztt
19 Nov 21
Cyclo Therapeutics Announces Pricing of $11.7 Million Underwritten Public Offering of Common stock
4:04pm
8-K
EX-10.1
m87p8u42v
16 Aug 21
Entry into a Material Definitive Agreement
4:52pm
8-K
EX-1.1
p8cpe94k zsa
11 Dec 20
Cyclo Therapeutics Announces Pricing of $12.5 Million Public Offering
4:02pm
- Prev
- 1
- Next